Serum Interleukin-6 Levels in Adult Acute Myelogenous Leukemia: Relationship with Disease Characteristics and Outcome

References

• Van Snick J. Interleukin‐6: an overview. Annu. Rev. Immunol. 1990; 8: 253
   PubMed Web of Science ®Google Scholar
• Heinrich P. C., Castell J. V., Andus T. Interleukin‐6 and the acute phase response. Biochem. J. 1990; 265: 621
   PubMed Web of Science ®Google Scholar
• Nachbauer D., Herold M., Maneschg A., Huber H. Serum levels of interleukin‐6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. Ann. Hematol. 1991; 62: 54
   PubMed Web of Science ®Google Scholar
• Lopez M., Maroc N., Kerangueven F., Bardin F., Courcoul M., Lavezzi C., Birg F., Mannoni P. Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Exp. Hematol. 1991; 19: 797
   PubMed Web of Science ®Google Scholar
• Hoang T., Goncalves O., Wong G. G., Clark S. C. Interleukin‐6 enhances growth factor‐dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988; 72: 823
   PubMed Web of Science ®Google Scholar
• Brach M. A., Löwenberg B., Mantovani L., Schwulera U., Mertelsmann R., Hermann F. Interleukin‐6 (IL‐6) is an intermediate in IL‐1 ‐induced proliferation of leukemic human megakaryoblasts. Blood 1990; 76: 1972
   PubMed Web of Science ®Google Scholar
• Fuse A., Kakuda H., Shima Y., Van Damme J., Biliau A., Sato T. Interleukin‐6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 1991; 77: 32
   PubMed Web of Science ®Google Scholar
• Stasi R., Venditti A., Del Poeta G., Tribalto M., Coppetelli U., Zaccari G., Papa G. High interleukin‐6 plasma levels in acute promyelocytic leukemia. Ann. Hematol. 1992; 64: 303
   PubMed Web of Science ®Google Scholar
• Dubois C., Schlageter M. H., De Gentille A., Guidez F., Balitrand N., Toubert M. E., Krawice I., Fenaux P., Castaigne S., Najean Y., Degos L., Chomienne C. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood 1994; 83: 3264
   PubMed Web of Science ®Google Scholar
• Herold M., Schmalzl F., Zwierzina H. Increased serum interleukin 6 levels in patients with myelodysplastic syndromes. Leuk. Res. 1992; 16: 585
   PubMed Web of Science ®Google Scholar
• Suzuki T., Mono T., Tohda S., Nagata K., Yamashita Y., Imai Y., Aoki N., Hirashima K., Nara N. Effects of interleukin‐6 and granulocyte colony‐stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients. Jpn. J. Cancer Res. 1990; 81: 979
   PubMedGoogle Scholar
• Brach M. A., Cicco N. A., Riedel D., Hirano T., Kishimoto T., Mertelsmann R. H., Hermann F. Mechanisms of differential regulation of interleukin‐6 mRNA accumulation by tumor necrosis factor alpha and lymphotoxin during monocytic differentiation. FEBS Lett. 1990; 263: 349
   PubMed Web of Science ®Google Scholar
• Beauchemin V., Villeneuve L., Rodriguez‐Cimadevilla J. C., Rajotte D., Kennedy J. S., Clark S. C., Hoang T. Interleukin‐6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin‐1 and biological implications. J. Cell Physiol. 1991; 148: 353
   PubMed Web of Science ®Google Scholar
• Schindler R., Mancilla J., Endres S., Gborbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of IL‐6, IL‐I and TNF in human blood mononuclear cells: IL‐6 suppresses IL‐1 and TNF. Blood 1990; 75: 40
   PubMed Web of Science ®Google Scholar
• Luger T. A., Krutmann J., Kirnbauer R., Urhanski A., Schwarz T., Klappacher G., Köck A., Micksche M., Malejczyk J., Schauer E., May L. T., Sehgal P. B. IFN‐β2/IL‐6 augments the activity of human natural killer cells. J. Immunol. 1989; 143: 1206
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French‐American‐British Cooperative Group. Ann. Intern. Med. 1985; 103: 626
   PubMedGoogle Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO). Br. J. Haematol. 1991; 78: 325
   PubMed Web of Science ®Google Scholar
• Ellison R. R., Holland J. F., Weil M., Jacquillat C., Boiron M., Bernard J., Sawitsky A., Rosner F., Gussoff B., Silver R. T., Karanas A., Cuttner J., Spurr C. L., Hayes D. M., Bloom J., Leone L. A., Haurani F., Kyle R., Hutchison J. L., Forcier R. J., Moon J. H. Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood 1968; 32: 507
   PubMed Web of Science ®Google Scholar
• Verhoef G. E. G., De Schouwer P., Ceuppens J. L., Van Damme J., Goossens W., Boogaerts M. A. Measurement of serum cytokine levels in patients with myelodysplasic syndromes. Leukemia 1992; 6: 1268
   PubMed Web of Science ®Google Scholar
• Boggs D. R., Frei E., III. Clinical studies of fever and infection in cancer. Cancer 1960; 13: 1240
   Web of Science ®Google Scholar
• Gauldie J., Richards C., Harnish D., Landsdorf O., Baumann H. Interferon beta2/B‐cell stimulatory factor type 2 shares identity with monocyte‐derived hepatocyte‐stimulating factor and regulates the acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 1987; 84: 7251
   PubMed Web of Science ®Google Scholar
• Geiger T., Andus T., Klapproth J., Hirano T., Kishimoto T., Heinrich P. C. Induction of rat acute‐phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 1988; 18: 717
   PubMed Web of Science ®Google Scholar
• Nijsten M. W., De Groot E. R., Ten Duis H. J., Klasen H. J., Hack C. E., Aarden L. A. Serum levels of interleukin‐6 and acute phase responses (letter). Lancet 1987; 2: 921
   PubMed Web of Science ®Google Scholar
• Hack C. E., De Groot E. R., Felt‐Bersma R. J., Muijens J., Strack‐van‐Schidjndel R. J., Eerenberg‐Beimer A. J., Thifs L. G., Aarden L. A. Increased plasma level of interleukin‐6 in sepsis. Blood 1989; 74: 1704
   PubMed Web of Science ®Google Scholar
• Calandra T., Gerain J., Heumann D., Baumgartner J. D., Glauser M. P. High circulating levels of interleukin‐6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 1991; 91: 23
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of interleukin‐6. Blood 1989; 74: 1
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirano T., Kishimoto T., Lindemann A., Mertelsmann R. H., Hermann F. Participation of the cytokines interleukin‐6, tumor necrosis factor‐alpha, and interleukin‐I‐beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest 1989; 84: 451
   PubMed Web of Science ®Google Scholar
• Van der Schoot C. E., Jansen P., Poorter M., Wester M. R., Von dem Borne A. E. G., Aarden L. A., Von Oers R. H. J. Interleukin‐6 and interleukin‐I production in acute myeloid leukemia with monocytoid differentiation. Blood 1989; 74: 2081
   PubMed Web of Science ®Google Scholar
• Wong G. G., Clark S. C. Multiple actions of interleukin 6 within a cytokine network. Immunol. Today 1988; 9: 137
   PubMedGoogle Scholar
• Jarvis L. J., LeBien T. W. Stimulation of human bone marrow stromal cell tyrosine kinases and IL‐6 production by contact with B lymphocytes. J. Immunol. 1995; 155: 2359
   PubMed Web of Science ®Google Scholar
• Uchiyama H., Barut B. A., Mohrbacher A. F., Chauhan D., Anderson K. C. Adhesion of human myeloma‐derived cell lines to bone marrow stromal cells stimulates interleukin‐6 secretion. Blood 1993; 82: 3712
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Kantarjian H., Weltzler M., Estrov Z., Estey E., Troutman‐Worden K., Gutterman J. U., Talpaz M. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage. Exp. Hematol. 1993; 21: 80
   PubMed Web of Science ®Google Scholar
• Ludwig H., Nachbauer D. M., Fritz E., Krainer M., Huber H. Interleukin‐6 is a prognostic factor in multiple myeloma (letter). Blood 1991; 77: 2794
   PubMed Web of Science ®Google Scholar